by Jessica Etheridge | Jul 24, 2023 | Company Details, News and Events
New Day Diagnostics LLC is pleased to announce that it has entered into an asset purchase agreement with Epigenomics AG (Frankfurt Prime Standard: ECX, OTCQX: EPGNY), a molecular diagnostics company focused on blood testing for the early detection of cancer. This...
by Jessica Etheridge | Jul 5, 2023 | Company Details, News and Events
KNOXVILLE, Tenn. & BOCA RATON, Fla.–(BUSINESS WIRE)–EDP Biotech Corp. (EDP Biotech) and New Day Diagnostics, LLC (New Day Diagnostics) are pleased to announce their combination, forming a vertically integrated force in the expedited development and...
by Jessica Etheridge | Apr 25, 2023 | News and Events, Products & Pipeline, Research & Development
ColoPlex Biomarker Data Published in Journal of Clinical Oncology Novel blood-based biomarker candidates in screening for colorectal cancer. Jason Lee Liggett, Mathias M Petersen, Jakob Kleif, Morten Rasmussen, Lars Nannestad Jørgensen, Jakob Benedict Seidelin, Mogens...
by Jessica Etheridge | Jan 12, 2023 | Company Details, News and Events
Sam Libby joins EDP Biotech Corporation as Head of Mergers & Acquisitions and Corporate Development to expand investments and create new corporate relationship opportunities as the company grows. KNOXVILLE, Tenn., January 12, 2023–(BUSINESS WIRE)–EDP...
by Jessica Etheridge | Jul 6, 2022 | News and Events
Want to chat with us during AACC? We want to see you in Chicago. Use the link below to schedule time with EDP during the show. We’d love to schedule some time to meet you at AACC next week. In attendance will be Eric Mayer, CEO, Jon Dancy our Business...
by Jessica Etheridge | Aug 18, 2021 | News and Events
By Abby Kousouris Published: Aug. 17, 2021 at 7:25 PM EDT KNOXVILLE, Tenn. (WVLT) – A local Knoxville company says they’re seeing more demand for COVID-19 testing. EDP Biotech Corporation has different options available for people who want to find out if they...